Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer.

Victoria Brennan,Alexander Spektor,Christopher Sweeney,Atish D. Choudhury,Dana E. Rathkopf,Mark Pomerantz,Lauren Hertan,Neil E. Martin,Paul L. Nguyen,Tracy A. Balboni,Mai Anh Huynh,Martin T. King

Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer.

2021

Victoria Brennan
Alexander Spektor
Christopher Sweeney
Atish D. Choudhury
Dana E. Rathkopf
Mark Pomerantz
Lauren Hertan
Neil E. Martin
Paul L. Nguyen
Tracy A. Balboni
Mai Anh Huynh
Martin T. King

121Background: Outcomes of stereotactic body radiation therapy (SBRT) with respect to androgen receptor signaling inhibitors (ARSI) have not been characterized for metastatic prostate cancer. Our p...

Keywords:

Androgen receptor
Cancer research
Prostate cancer
stereotactic body radiation therapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations